Walleye Capital LLC Harrow Health, Inc. Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$17.37 - $28.08 $1.31 Million - $2.12 Million	75,382 New	75,382 $1.44 Million
Q3 2022 Nov 14, 2022	BUY	$6.57 - $24.88 $15,367 - $58,194	2,339 Added 15.85%	17,099 $206,000
Q2 2022 Aug 08, 2022	BUY	$5.75 - $7.74 $84,870 - $114,242	14,760 New	14,760 $107,000
Q3 2021 Nov 15, 2021	SELL	$6.99 - $10.6 $365,087 - $553,638	-52,230 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.68 - $11.07 $348,896 - $578,186	52,230 New	52,230 $485,000
Q1 2021 May 17, 2021	SELL	$6.26 - $11.03 $76,998 - $135,669	-12,300 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.76 - $6.93 $58,548 - $85,239	12,300 New	12,300 $84,000

176

21.4M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.06B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.